Clinical Trial Update: An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension [NA]

View source ↗

Summary

An open-label study evaluating an ophthalmic solution to lower intraocular pressure in patients with ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension

Snippet

Sponsor: Chakshu Research, Inc. | Conditions: Ocular Hypertension | NA | Status: COMPLETED